ArticleFrontiers in immunology2026

Favorable coronary outcomes following IL-6 blockade with tocilizumab in IVIG-resistant kawasaki disease: a case series.

Jing Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.